Itay Israel Shemesh Email Address

Medical Science Liaison

NanoString Technologies provides life science tools for translational research and molecular diagnostic products. The company's nCounter Analysis System has been employed in life sciences research since it was first introduced in 2008 and has been cited in more than 800 peer-reviewed publications. The nCounter Analysis System offers a cost-effective way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision, facilitating a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. The company's technology has also been applied to diagnostic use. The Prosigna Breast Cancer Prognostic Gene Signature Assay together with the nCounter Dx Analysis System is FDA 510(k) cleared for use as a prognostic indicator for distant recurrence of breast cancer.

• I am a highly motivated and confident PhD student (final stages) with excellent oral communication skills. • I led collaborations with medical doctors in Israel and postdoc fellows abroad. • I have spent most of my academic years studying pre-clinical drug effects on diverse disease models, completing both my BSc and MSc with honors. • Living in the United States, I led a multi-national research project with the National Institutes of Health (NIH), Bethesda, MD. • I see myself as a sociable, patient and responsible person.